Tasting Plant Forward Meals
Sara Maksi · with Alliance for Potato Research and Education, Penn State University · NCT07202988
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18–25 · All sexes
- Healthy volunteers
- Accepted
- Study type
- Interventional · Not applicable
- Target enrollment
- 80
- US sites recruiting
- 1
- Study start
- January 30, 2026
- Record last updated
- October 16, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
This study aims to examine how the amount of potato and form of potato within a meal impacts intake and acceptability of other non-starchy vegetables.
Being studied: vegetable combination 1; vegetable combination 2; vegetable combination 3; vegetable combination 4; vegetable combination 5
Conditions: Dietary Exposure
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- between the ages of 18-25 years
Exclusion Criteria
- unable to complete all study procedures
- food allergies to any of the study food
Recruiting US locations
University of Kentucky
Lexington, KY 40503
Site contact: Sara Maksi Maksi · 859-257-2327 · sara.maksi@uky.edu
Study contacts (from the official record)
- Sara J Maksi · 859-257-2327 · sara.maksi@uky.edu
Similar studies in Kentucky
All nutrition & metabolism studies in Kentucky →- RecruitingHealthy volunteers
A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events
Cleerly, Inc.
- Location
- Edgewood, KY + 121 other US sites
- Eligibility basics
- Ages 55+
- RecruitingPhase 3
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
Hoffmann-La Roche
- Location
- Louisville, KY + 121 other US sites
- Eligibility basics
- Ages 18–80
- RecruitingPhase 3
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
Hoffmann-La Roche
- Location
- Louisville, KY + 112 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 3
A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis
Akero Therapeutics, Inc
- Location
- Louisville, KY + 131 other US sites
- Eligibility basics
- Ages 18–80